Human T cells can target more than 1,400 sites on SARS-CoV-2

Human T cells can target more than 1,400 sites on SARS-CoV-2 virus
In a new paper, scientists from La Jolla Institute for Immunology (LJI) bring together research findings from COVID-19 researchers around the world. The results are striking: human T cells can target more than 1,400 sites on the SARS-CoV-2 virus.
"Our lab and many others have shown this very broad and diverse T cell response," says LJI Research Assistant Professor Daniela Weiskopf, Ph.D., co-author of the
Cell Host & Microbe review.
This kind of research review, called a "meta-analysis," pools the results of multiple studies, and the researchers give close consideration to how the studies were conducted.

Related Keywords

Alba Grifoni , Alessandro Sette , Emily Henderson , Research Assistant Professor Daniela Weiskopf , National Institute Of Allergy , Jolla Institute For Immunology , Vaccine Research , Assistant Professor Daniela Weiskopf , Cell Host , Infectious Disease , Immune Epitope Database , National Institute , Infectious Diseases , Cell , Enetic , Immune System , Mmunology , Pandemic , Mh , Research , Cars , Ars Cov 2 , Virus , Alessandro செத்தே , எமிலி ஹென்டர்சன் , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , ஜொல்லா நிறுவனம் க்கு நோயெதிர்ப்பு , தடுப்பூசி ஆராய்ச்சி , செல் தொகுப்பாளர் , தொற்று நோய் , தேசிய நிறுவனம் , தொற்று நோய்கள் , செல் , ஏச் , அரசு ,